HerAnova™ Commercializes HerResolve™ across a Growing Network of IVF Centers in the U.S.
HerResolve™ Is the First and Only Commercially Available Non-Invasive Blood Test for Endometriosis BOSTON, MA, UNITED STATES, February 23, 2026 /EINPresswire.com/ -- HerAnova™ Lifesciences, a leader in non-invasive diagnostic innovation for …